Summary

Research Review Scope
The pharmaceutical market is one of the biggest industries in the world, and it is continuously growing. Continuous and ongoing research and development are happening in the pharmaceutical market, with the entry of new drugs and the performance of the current drugs. However, a drug's entry into the market takes around 12-13 years, but the market for existing drugs keeps soaring, which is why the pharmaceutical market keeps growing.
Research and development play a vital role in the growth of the pharmaceutical market, driven by technological and scientific advancements, especially in cell and gene therapies. The market is affected by stringent regulatory and reimbursement policies and escalating research and development costs. Artificial intelligence can be considered crucial with its usage in multiple fields of pharmaceuticals, such as drug discovery, clinical trials, drug screening, personalized medicine, supply chain management, regulatory compliance, pharmacovigilance, and marketing insights. Generative AI tools help accelerate drug discovery by automating tedious and time-consuming tasks.
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2023 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2023:
-PHM281A Anti Obesity Drugs Market
- PHM013J Drugs of Abuse Testing: Technologies and Global Markets
- BIO009H Global Markets for Bioengineered Protein Drugs
- HLC026G The Global Market for Pain Management Drugs and Devices
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Foreword
Research Review Scope
Chapter 2 Global Market for Anti-obesity Drugs (PHM281A)
Anti-obesity Drugs
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Market Outlook
Market Summary
Market Overview of Anti-obesity Drugs
Definitions of Adult Obesity and Overweight
Rising Prevalence of Obesity
Impact of Obesity on Global Economy
Increasing Awareness Regarding Obesity
Global Market for Anti-obesity Drugs, by Type
Prescription Drugs
Over-the-Counter Anti-obesity Drugs
Global Market for Anti-obesity Drugs, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Market for Anti-obesity Drugs, by Region
North America
Europe
Asia-Pacific
Rest of the World
ESG Developments of Anti-obesity Drugs
Importance of ESG in Anti-obesity Drugs Industry
ESG Pillars in the Anti-obesity Drug Industry
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Anti-obesity Drug Industry
Concluding Remarks from BCC
Chapter 3 Drugs of Abuse Testing: Technologies and Global Markets (PHM013J)
Drugs of Abuse Testing
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Summary and Highlights
Market and Technology Background of Drugs of Abuse Testing
Overview
Testing Technologies
Single Tests vs. Multiparameter Tests
DOA Screening
Porter’s Five Forces Analysis of Drugs of Abuse Testing
Market Dynamics of Drugs of Abuse Testing
Market Drivers
Market Restraints
Market Opportunities
Regulatory Scenario of Drugs of Abuse Testing
North America
South America
Central America and the Caribbean
Europe
Asia-Pacific
Global Drugs of Abuse Testing Market, by Drug Type
Alcohol
Amphetamine and Methamphetamine
Cannabis/Marijuana
Cocaine
Opioids
Others
Global Drugs of Abuse Testing Market, by End User
Drug Testing Laboratories
Hospitals
Workplaces
Others
Market Breakdown of Drugs of Abuse Testing, by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 4 Global Markets for Bioengineered Protein Drugs (BIO009H)
Bioengineered Protein Drugs
Study Goals and Objectives
Scope of This Report
Market Summary
Market and Technology Background of Bioengineered Protein Drugs
Protein Drugs Overview
Bioengineered Protein Drugs
Manufacturing Technologies of Bioengineered Protein Drugs
Fractionation/Extraction from Natural Sources (Human/Animal)
Microbial Fermentation and Bioreactors
Transgenics
Mammalian Cell Culture
Market Dynamics of Bioengineered Protein Drugs
Market Driver
Market Challenges
Market Breakdown of Bioengineered Protein Drugs by Drug Type
Overview
Monoclonal Antibodies (mAbs)
Peptide Hormones
Vaccines
Fusion Proteins
Blood Factors
Peptide Antibiotics
Cytokines
Therapeutic Enzymes
Market Breakdown of Bioengineered Protein Drugs, by Disease
Overview
Market Breakdown of Bioengineered Protein Drugs, by Region
North America Market Revenue, by Drug Type
Europe Market Revenue, by Drug Type
Emerging Markets Revenue, by Drug Type
Regulatory Aspects and New Approvals of Bioengineered Protein Drugs Market
New Approvals
Emerging Trends/Upcoming Technologies in the Market
Bi- and Multi-Specific Antibodies
Key Trends in Biopharmaceutical Industry
Chapter 5 Global Market for Pain Management Drugs and Devices (HLC026G)
Pain Management Drugs and Device
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Market Outlook
Market Summary
Highlights of the Market for Pain Management Drugs and Devices
Market Overview of Pain Management Drugs and Device
History of Pain and Pain Treatment
The Perception of Pain
Types of Pain
Assessment of Pain
How Pain is Diagnosed
How Pain is Treated
Market Dynamics of Pain Management Drugs and Device
Market Drivers
Market Restraints
Market Challenges
Market Breakdown of Pain Management Drugs and Device, by Product
Pharmaceuticals
Pain Management Devices
Market Breakdown of Pain Management Drugs and Device, by Application
Musculoskeletal Pain
Post-operative Pain
Neuropathic Pain
Cancer Pain
Migraine/Headache
Other Applications
Market Breakdown of Pain Management Drugs and Device, by Region
North America
Europe
Asia-Pacific
Rest of the World
ESG Development of Pain Management Drugs and Device
Introduction to ESG
Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective
Case Study
Concluding Remarks from BCC
Emerging Technologies of Pain Management Drugs and Device
Overview
Technology Advancements in Opioid Drugs
Technology Advancements in Non-narcotic Drugs
Technology Advancements in Neuromodulation Devices
Technology Advancements in Infusion Pumps
Trends in Pain Management
Chapter 6 Appendix
Methodology
Analyst’s Credentials